Volume 14, Number 9—September 2008
Research
Pediatric Parapneumonic Empyema, Spain
Table 4
Serotype | No. (%) patients with IPD, n = 126 | STs detected: diseases detected (no. patients), n = 111 | Carriage, no. (%) patients, n = 194 | STs detected in carriage (no. patients) | OR (95% CI) |
---|---|---|---|---|---|
1 | 29 (23) | 228: P (7), PPE (6), A (1), B (1) | 1 (1) | 306 (1) | 57.7 (7.7–429.9) |
306‡ : PPE (7), P (3) | |||||
304§: PPE (1) |
|||||
14 | 22 (17) | 156: P (7), PPE (4), M (2) | 15 (8) | 156 (12) | 2.5 (1.3–5.1) |
9: PPE (1) | 409 (1) | ||||
62: P (1) | 1684 (1) | ||||
124: PPE (1) | 2607 (1) | ||||
2204: M (1) |
|||||
7F |
10 (8) |
191: PPE (4), P (3), M (1), B (1) |
3 (2) |
191 (3) |
5.5 (1.5–20.3) |
19A | 10 (8) | 276: PPE (2), M (2), P (1) | 13 (7) | 276 (2) | 1.2 (0.5–2.8) |
202: B (1) | 202 (3) | ||||
1201: PPE (1) | 1201 (1) | ||||
199 (2) | |||||
433 (2) | |||||
392 (1) | |||||
2109 (1) | |||||
2609 (1) |
|||||
3 | 6 (5) | 260: PPE (1), P (1), M (1) | 7 (4) | 180 (3) | 1.6 (0.5–4.6) |
180: PPE (1) | 260 (2) | ||||
2200 (2) |
|||||
6A | 5 (4) | 1150: M (1) | 24 (12) | 338 (8) | 0.29 (0.1–0.79) |
1668: S (1) | 386 (5) | ||||
1876: M (1) | 1876 (3) | ||||
224 (2) | |||||
327 (1) | |||||
392 (1) | |||||
448 (1) | |||||
473 (1) | |||||
2201 (1) | |||||
2611 (1) |
|||||
5 | 3 (2) | 289: PPE (2) | 2 (1) | 289 (1) | 2.3 (0.39–14.2) |
1223: P (1) |
1540 (1) |
||||
19F | 3 (2) | 87: C (1), B (1) | 8 (4) | 81 (3) | 0.57 (0.15–2.2) |
88: M (1) | 87 (1) | ||||
179 (2) | |||||
63 (1) | |||||
2615 (1) |
|||||
9V |
1 (1) |
838: B (1) |
3 (2) |
838 (3) |
0.5 (0.05–5) |
8 | 1 (1) | 53: M (1) | 0 | – |
*Culture-positive isolates only for IPD. Boldface indicates a statistically significant result and represents STs that were identified among pleural fluids during the study period in Seville, Malaga, and Barcelona. An OR demonstrating the potential for each serotype to cause invasive disease, relative to its prevalence in nasopharyngeal carriage, was also calculated (16). Serotypes 6A, 19F, and 9V were associated with PPE in Barcelona (but not Seville and Malaga) and are included here for a complete list of invasive serotypes with any association to PPE among the 3 locations; however, data presented here are only from Seville and Malaga. Serotypes identified in IPD cases but not among children with PPE: 6B, 11, 13, 15A, 16, 18C, 22, 23A, 23B, 23F, 24, 33, 34, 38.
†PPE, pediatric parapneumonic empyema; IPD, invasive pneumococcal disease; ST, sequence type; OR, odds ratio; CI, confidence interval; A, arthritis; B, occult bacteremia; P, pneumonia; M, meningitis; S, sepsis; C, orbital cellulitis.
‡First detected in 2003.
§First detected in 2002.
References
- Chonmaitree T, Powell KR. Parapneumonic pleural effusion and empyema in children. Review of a 19-year experience, 1962–1980. Clin Pediatr (Phila). 1983;22:414–9. DOIPubMedGoogle Scholar
- Tan TQ, Mason EO Jr, Wald ER, Barson WJ, Schutze GE, Bradley JS, Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae. Pediatrics. 2002;110:1–6. DOIPubMedGoogle Scholar
- Hsieh YC, Hsueh PR, Lu CY, Lee PI, Lee CY, Huang LM. Clinical manifestations and molecular epidemiology of necrotizing pneumonia and empyema caused by Streptococcus pneumoniae in children in Taiwan. Clin Infect Dis. 2004;38:830–5. DOIPubMedGoogle Scholar
- Eastham KM, Freeman R, Kearns AM, Eltringham G, Clark J, Leeming J, Clinical features, aetiology and outcome of empyema in children in the north east of England. Thorax. 2004;59:522–5. DOIPubMedGoogle Scholar
- Deiros Bronte L, Baquero-Artigao F, Garcia-Miguel MJ, Hernández González N, Peña Garcia P, del Castillo Martin F. Parapneumonic pleural effusion: an 11-year review. An Pediatr (Barc). 2006;64:40–5. DOIPubMedGoogle Scholar
- Byington CL, Spencer LY, Johnson TA, Pavia AT, Allen D, Mason EO, An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema risk factors and microbiological associations. Clin Infect Dis. 2002;34:434–40. DOIPubMedGoogle Scholar
- Obando I, Arroyo L, Sánchez Tatay D, Moreno D, Hausdorff WP, Brueggemann AB. Molecular typing of pneumococci causing parapneumonic empyema in Spanish children using multilocus sequence typing directly on pleural fluid samples. Pediatr Infect Dis J. 2006;25:962–3. DOIPubMedGoogle Scholar
- Le Monnier A, Carbonnelle E, Zahar JR, Le Bourgeois M, Abachin E, Quesne G, Microbiologic diagnosis of empyema in children: comparative evaluations by culture, polymerase chain reaction, and pneumococcal antigen detection in pleural fluids. Clin Infect Dis. 2006;42:1135–40. DOIPubMedGoogle Scholar
- O’Brien KL, Nohynek H; WHO Pneumococcal Vaccine Trials Carriage Working Group. Report from a WHO working group: standard method for detecting upper respiratory carriage of Streptococcus pneumoniae. Pediatr Infect Dis J. 2003;22:e1–11. DOIPubMedGoogle Scholar
- Clinical Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 18th informational supplement. CLSI document M100-S16. Wayne (PA): The Institute; 2008.
- Corless CE, Guiver M, Borrow R, Edwards-Jones V, Fox AJ, Kaczmarski EB. Simultaneous detection of Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae in suspected cases of meningitis and septicemia using real-time PCR. J Clin Microbiol. 2001;39:1553–8. DOIPubMedGoogle Scholar
- Toikka P, Nikkari S, Ruuskanen O, Leinonen M, Mertsola J. Pneumolysin PCR-based diagnosis of invasive pneumococcal infection in children. J Clin Microbiol. 1999;37:633–7.PubMedGoogle Scholar
- Tarragó D, Fenoll A, Sánchez-Tatay D, Arroyo LA, Muñoz-Almagro C, Esteva C, Identification of pneumococcal serotypes from culture-negative clinical specimens by novel real-time PCR. Clin Microbiol Infect. In press.
- Enright MC, Spratt BG. A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology. 1998;144:3049–60.PubMedGoogle Scholar
- Enright MC, Knox K, Griffiths D, Crook DW, Spratt BG. Molecular typing of bacteria directly from cerebrospinal fluid. Eur J Clin Microbiol Infect Dis. 2000;19:627–30. DOIPubMedGoogle Scholar
- Brueggemann AB. Griffiths, Meats E, Peto T, Crook DW, Spratt BG. Clonal relationships between invasive carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. J Infect Dis. 2003;187:1424–32. DOIPubMedGoogle Scholar
- Sandgren A, Sjostrom K, Olsson-Liljequist B, Christensson B, Samuelsson A, Kronvall G, Effect of clonal and serotype-specific properties on the invasive capacity of Streptococcus pneumoniae. J Infect Dis. 2004;189:785–96. DOIPubMedGoogle Scholar
- Brueggemann AB, Spratt BG. Geographic distribution and clonal diversity of Streptococcus pneumoniae serotype 1 isolates. J Clin Microbiol. 2003;41:4966–70. DOIPubMedGoogle Scholar
- Brueggemann AB, Peto TE, Crook DW, Butler JC, Kristinsson KG, Spratt BG. Temporal and geographic stability of the serogroup-specific invasive potential of Streptococcus pneumoniae in children. J Infect Dis. 2004;190:1203–11. DOIPubMedGoogle Scholar
- Byington CL, Korgenski K, Daly J, Ampofo K, Pavia A, Mason EO. Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema. Pediatr Infect Dis J. 2006;25:250–4. DOIPubMedGoogle Scholar
- Weil-Olivier C, Levy C, Marguet C, Sardet A, de La Rocque F, Lecuyer A, Multicenter pediatric retrospective study on pneumonia with empyema in France. Arch Pediatr. 2005;12:823–6. DOIPubMedGoogle Scholar
- Tan TQ; US Pediatric Multicenter Pneumococcal Surveillance Study Group. 5th International Symposium on Pneumococci and Pneumococcal Disease; Alice Springs, Northern Territory, Australia; 2006 Apr 2–6.
- Fenoll A, Tarrago D, Casal J. Impacto de la vacuna neumocócica sobre la epidemiología de serotipos y resistencia de neumococo. In: Navarro-Merino M, Andres-Martin A, Pérez-Perez G, editors. Avances en Neumología Pediátrica. Majadahonda (Spain): Ergon; 2008. p. 35–48.
- Calbo E, Díaz A, Cañadell E, Fábrega J, Uriz S, Xercavins M, Invasive pneumococcal disease among children in a health district of Barcelona: early impact of pneumococcal conjugate vaccine. Clin Microbiol Infect. 2006;12:867–72. DOIPubMedGoogle Scholar
- Barricarte A, Castilla J, Gil-Setas A, Torroba L, Navarro-Alonso JA, Irisarri F, Effectiveness of the 7-valent pneumococcal conjugate vaccine: a population-based case-control study. Clin Infect Dis. 2007;44:1436–41. DOIPubMedGoogle Scholar
- Dagan R, Gradstein S, Belmaker I, Porat N, Siton Y, Weber G, An outbreak of Streptococcus pneumoniae serotype 1 in a closed community in southern Israel. Clin Infect Dis. 2000;30:319–21. DOIPubMedGoogle Scholar
- Henriques Normark B, Kalin M, Ortqvist A, Akerlund T, Liljequist BO, Hedlund J, Dynamics of penicillin-susceptible clones in invasive pneumococcal disease. J Infect Dis. 2001;184:861–9. DOIPubMedGoogle Scholar
- Hausdorff WP. The roles of pneumococcal serotypes 1 and 5 in paediatric invasive disease. Vaccine. 2007;25:2406–12. DOIPubMedGoogle Scholar
- Enright MC, Fenoll A, Griffiths D, Spratt BG. The three major Spanish clones of penicillin-resistant Streptococcus pneumoniae are the most common clones recovered in recent cases of meningitis in Spain. J Clin Microbiol. 1999;37:3210–6.PubMedGoogle Scholar
- Hedlund J, Sorberg M, Henriques Normark B, Kronwall G. Capsular types and antibiotic susceptibility of invasive Streptococcus pneumoniae among children in Sweden. Scand J Infect Dis. 2003;35:452–8. DOIPubMedGoogle Scholar
- UK Health Protection Agency. Pneumococcal serotype distribution for samples referred for serotyping epidemiological years (July–June): 2000/1–2005/6 [cited 2007 Jun 22]. Available from http://www.hpa.org.uk
- Sjöström K, Spindler C, Ortqvist A, Kalin M, Sandgren A, Kühlmann-Berenzon S, Clonal and capsular types decide whether pneumococci will act as a primary or opportunistic pathogen. Clin Infect Dis. 2006;42:451–9. DOIPubMedGoogle Scholar
- Silva NA, McCluskey J, Jefferies JM, Hinds J, Smith A, Clarke SC, Genomic diversity between strains of the same serotype and multilocus sequence type among pneumococcal clinical isolates. Infect Immun. 2006;74:3513–8. DOIPubMedGoogle Scholar
- Watson M, Gilmour R, Menzies R, Ferson M, McIntyre P; New South Wales Pneumococcal Network. The association of respiratory viruses, temperature, and other climatic parameters with the incidence of invasive pneumococcal disease in Sydney, Australia. Clin Infect Dis. 2006;42:211–5. DOIPubMedGoogle Scholar
- Hausdorff WP, Brueggemann AB, Hackell J, Scott JAG. Pneumococcal serotype epidemiology. In: Siber GR, Klugman KP, Makela PH, editors. Pneumococcal vaccines: the impact of conjugate vaccines. Washington: ASM Press; 2008. p. 139–62.